Shareholding14 May 2026, 08:44 am
Kunjal Unadkat Increases Stake in Aptus Pharma to 8.64%
AI Summary
Kunjal Unadkat increased their shareholding in Aptus Pharma Limited to 8.64% through the acquisition of 18,000 shares on May 11, 2026. This acquisition represents a 0.26% increase in the total share capital. The disclosure was made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Key Highlights
- Kunjal Unadkat acquired 18,000 shares of Aptus Pharma on May 11, 2026.
- The acquisition increased Unadkat's stake in Aptus Pharma to 8.64%.
- The transaction was disclosed under SEBI's Takeover Regulations.
- Aptus Pharma's equity share capital remains at 68,60,000 shares after the acquisition.
Price Impact
More from APPL